DeepHealth develops AI-powered health informatics and radiology software, including the cloud-native DeepHealth OS and imaging and population health suites used across 300+ sites globally.
DeepHealth develops AI-powered health informatics and radiology software, with technical work spanning artificial intelligence, medical imaging and computer vision, health informatics, cloud-native platforms, clinical decision support and population health analytics. The company builds cloud-native, AI-infused software intended to improve clinical accuracy and operational efficiency across the radiology continuum, and it holds FDA-cleared AI applications.
Its flagship product, DeepHealth OS, is a cloud-native operating system that unifies data across clinical and operational workflows and personalises AI-powered workspaces for participants in the radiology ecosystem. The wider portfolio includes the Enterprise Imaging Diagnostic Suite and Operations Suite, TechLive, and Population Health suites covering breast, prostate, chest/thyroid and neuro imaging.
DeepHealth reports deployments at more than 300 sites globally and software supporting over 10m mammograms a year. A 21% increase in breast cancer detection rate has been reported in landmark studies published in Nature Health. The company operates internationally and serves the radiology, healthcare, diagnostic imaging, population health, breast cancer screening and oncology verticals.
DeepHealth is a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT). Further detail is available at https://deephealth.com/.
